The biopharma community met at Munich in Germany for BIO-Europe 2023, where attendees from across the world took part in networking events to foster collaboration, last month. With a turnout of nearly 6000 participants and more than 150 exhibitors, the event hosted a number of panel discussions. In collaboration with our parent company, life science […]
Drug discovery and development is a long, costly, and high-risk process that takes over 10 to 15 years with an average cost of over $1 to $2 billion for each new drug to be approved for clinical use. For any pharmaceutical company or academic institution, it is a big achievement to advance a drug candidate […]
In precision oncology, tissue quality plays a pivotal role in maintaining data integrity. We explore the impact of standardizing tissue collection and processing on data quality, and how this helps enhance patient outcomes as well as our understanding of cancer. Insights from tissue samples play an important role across the drug life cycle – from […]
In this episode, we explore the synergy of quantum computing and drug discovery with the chief scientific officer and co-founder of Qubit Pharmaceuticals, Jean-Philip Piquemal. Qubit Pharmaceuticals was founded in 2020 with the vision of co-developing, with pharmaceutical and biotech companies, new, more effective, and safer drugs. The company uses its Atlas platform to discover […]
Singapore set out to become a global biotech hub back in 2000, and, although still awaiting its big success story in the industry, it is currently a leading hub in the APAC region for R&D, biopharma manufacturing, and commercial operations, with a growing startup ecosystem that includes numerous biotech companies. In 2000, the government in […]
Montreal, the largest city in Canada’s Quebec province, has seen a boom in life sciences over the years. Home to The Biotech City, a hub that connects and supports biopharmaceutical companies within the region as well as attracts talent from across the world, Montreal rivals the likes of Vancouver and Toronto, in being the leading […]
3D printing is capturing attention in the field of medicine of late. With the first 3D-printed drug being approved for the treatment of seizures, eight years ago, it was a consequential moment in healthcare, following which biotechs raced to step up personalized treatment. Now, with Chinese healthcare company Triastek turning heads after announcing promising clinical […]
Artificial intelligence (AI) is everywhere at the minute, seemingly being used in some capacity in almost every professional industry, including clinical research and trials. In fact, it is fair to say that AI has taken the biotech industry by storm, and the hype surrounding it has led to numerous AI startup companies coming onto the […]
A patient’s life was saved after researchers at the University of Pennsylvania, Castleman Disease Collaborative Network, Medidata, and Every Cure, used artificial intelligence to use an existing drug to treat idiopathic multicentric Castleman disease (iMCD). Every Cure and its partners are developing medical databases and AI algorithms to unlock new uses for existing medicines across […]
This week, we look at biomarkers, among other topics, with founder and CEO of Sapient, Mo Jain. We also have an overview of the Lund Spring Symposium with Dan Larhammar, Thoas Fioretos, and Sander van Deventer. Sapient Sapient is an end-to-end biomarker discovery organization dedicated to accelerating the mapping of circulating chemistries in humans through […]
Chat GPT – which is a large language model (LLM) and belongs to a family of artificial intelligence (AI) known as generative AI – has been a revelation for many people around the world, and, since its launch, has been used by professionals in many industries to assist with work-related tasks, such as editing and […]